These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 21719463

  • 1. Elucidation of the contribution of active site and exosite interactions to affinity and specificity of peptidylic serine protease inhibitors using non-natural arginine analogs.
    Hosseini M, Jiang L, Sørensen HP, Jensen JK, Christensen A, Fogh S, Yuan C, Andersen LM, Huang M, Andreasen PA, Jensen KJ.
    Mol Pharmacol; 2011 Oct; 80(4):585-97. PubMed ID: 21719463
    [Abstract] [Full Text] [Related]

  • 2. A cyclic peptidylic inhibitor of murine urokinase-type plasminogen activator: changing species specificity by substitution of a single residue.
    Andersen LM, Wind T, Hansen HD, Andreasen PA.
    Biochem J; 2008 Jun 15; 412(3):447-57. PubMed ID: 18318660
    [Abstract] [Full Text] [Related]

  • 3. The binding mechanism of a peptidic cyclic serine protease inhibitor.
    Jiang L, Svane AS, Sørensen HP, Jensen JK, Hosseini M, Chen Z, Weydert C, Nielsen JT, Christensen A, Yuan C, Jensen KJ, Nielsen NC, Malmendal A, Huang M, Andreasen PA.
    J Mol Biol; 2011 Sep 16; 412(2):235-50. PubMed ID: 21802428
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Distinctive binding modes and inhibitory mechanisms of two peptidic inhibitors of urokinase-type plasminogen activator with isomeric P1 residues.
    Jiang L, Zhao B, Xu P, Sørensen HP, Jensen JK, Christensen A, Hosseini M, Nielsen NC, Jensen KJ, Andreasen PA, Huang M.
    Int J Biochem Cell Biol; 2015 May 16; 62():88-92. PubMed ID: 25744057
    [Abstract] [Full Text] [Related]

  • 7. Selection of High-Affinity Peptidic Serine Protease Inhibitors with Increased Binding Entropy from a Back-Flip Library of Peptide-Protease Fusions.
    Sørensen HP, Xu P, Jiang L, Kromann-Hansen T, Jensen KJ, Huang M, Andreasen PA.
    J Mol Biol; 2015 Sep 25; 427(19):3110-22. PubMed ID: 26281711
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
    Bateman KS, Huang K, Anderson S, Lu W, Qasim MA, Laskowski M, James MN.
    J Mol Biol; 2001 Jan 26; 305(4):839-49. PubMed ID: 11162096
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structural basis of specificity of a peptidyl urokinase inhibitor, upain-1.
    Zhao G, Yuan C, Wind T, Huang Z, Andreasen PA, Huang M.
    J Struct Biol; 2007 Oct 26; 160(1):1-10. PubMed ID: 17692534
    [Abstract] [Full Text] [Related]

  • 12. Bicyclic peptide inhibitor of urokinase-type plasminogen activator: mode of action.
    Roodbeen R, Paaske B, Jiang L, Jensen JK, Christensen A, Nielsen JT, Huang M, Mulder FA, Nielsen NC, Andreasen PA, Jensen KJ.
    Chembiochem; 2013 Nov 04; 14(16):2179-88. PubMed ID: 24115455
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Binding of amino acid side-chains to S1 cavities of serine proteinases.
    Lu W, Apostol I, Qasim MA, Warne N, Wynn R, Zhang WL, Anderson S, Chiang YW, Ogin E, Rothberg I, Ryan K, Laskowski M.
    J Mol Biol; 1997 Feb 21; 266(2):441-61. PubMed ID: 9047374
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
    Wang Q, Shaltiel S.
    BMC Biochem; 2003 Jul 08; 4():5. PubMed ID: 12848892
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
    Jankun J, Skrzypczak-Jankun E.
    Cancer Biochem Biophys; 1999 Jul 08; 17(1-2):109-23. PubMed ID: 10738907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.